HERVIN: Trastuzumab and Vinorelbine in Metastatic Breast Cancer

NCT00401427 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: trastuzumab
DRUG: vinorelbine

Sponsor

National Cancer Institute, Naples